# Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

> **NCT04562805** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Elixir Medical Corporation** · enrollment: 2400 (estimated)

## Conditions studied

- Coronary Artery Disease
- Ischemic Heart Disease

## Interventions

- **DEVICE:** DynamX Bioadaptor
- **DEVICE:** Resolute Onyx

## Key facts

- **NCT ID:** NCT04562805
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-30
- **Primary completion:** 2024-09-05
- **Final completion:** 2028-07-31
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2024-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04562805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04562805, "Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04562805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*